PofoliaShared via Pofolia

Intervirology· 2013Q3

Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures

Peter Pushko, Paul Pumpens, Elmars Grens

Short summary

The FDA licensed the quadrivalent HPV vaccine (HPV4) for males aged 9-26 to prevent genital warts caused by HPV types 6 and 11, following its prior approval for females.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Sign in on the web to open

Field: Infectious Diseases

Infectious DiseasesMedicine